Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection

Keyphrases

• Chronic Hepatitis B Virus Infection 100%
• Antiretroviral Therapy 100%
• Liver 50%
• Hepatocellular Carcinoma 50%
• Hepatitis B Virus DNA 50%
• Hepatitis B Virus 50%
• Fibrosis 50%
• Prognostic Significance 50%
• Antiviral Agents 50%
• Advanced Liver Disease 50%
• Nucleos(t)ide Analogues 50%
• Viremia 50%
• Serum Hepatitis 50%
• Hepatic Decompensation 50%
• Virologic 50%
• Virus Interference 50%
• Biological Gradient 50%
• Chronic Hepatitis B Patients 50%
• DNA Level 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Hepatitis B Virus 100%
• Chronic Hepatitis B 100%
• Antiviral Therapy 100%
• Prospective Study 50%
• Liver Cell Carcinoma 50%
• Fibrosis 50%
• Liver Disease 50%
• Virus DNA 50%
• Antivirus Agent 50%
• Hepatitis B 50%
• Viremia 50%
• Decompensated Liver Cirrhosis 50%
• Diseases 50%

Immunology and Microbiology

• Hepatitis B 100%
• Hepatitis B Virus 66%
• Viremia 33%
• DNA Virus 33%